newsfilter
← Latest News
GlobeNewswire·

Acer Therapeutics Announces Topline Results from ACER-801 (Osanetant) Phase 2a Trial

NEWTON, Mass., March 17, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (NASDAQ:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and